Serum concentrations of erlotinib at a dose of 25 mg daily

by Costa, D.B., Kobayashi, S., Yeo, W.-L., Hamada, A.
Published 2014

SILVER - POLY(3-HIDROXY-BUTYRATE) [AG-PHB] NANOCOMPOSITE: A PREPARATIVE EVALUATION

by , S. Y. Yeo, W. L. Tan, M. Abu Bakar and J.Ismail
Published 2007

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma

by Chuah, B.Y.S., Yeo, W.-L., Guo, J.Y., Lim, S.-G., Yap, H.-L., Goh, B.-C., Lee, S.-C.
Published 2014

Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: Results of a meta-analysis of randomized controlled trials

by Soo, R.A., Loh, M., Mok, T.S., Ou, S.-H.I., Cho, B.-C., Yeo, W.-L., Tenen, D.G., Soong, R.
Published 2014

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

by Chan, D., Yeo, W.-L., Tiemsim Cordero, M., Wong, C.-I., Chuah, B., Soo, R., Tan, S.-H., Lim, S.-E., Goh, B.-C., Lee, S.-C.
Published 2014

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients

by Wong, A.L.-A., Yap, H.-L., Yeo, W.-L., Soong, R., Ng, S.-S., Wang, L.-Z., Cordero, M.T., Yong, W.-P., Goh, B.-C., Lee, S.-C.
Published 2014

Chemotherapy-induced tumor gene expression changes in human breast cancers

by Lee, S.-C., Xu, X., Lim, Y.-W., Lau, P., Sukri, N., Lim, S.-E., Yap, H.L., Yeo, W.-L., Tan, P., Tan, S.-H., McLeod, H., Goh, B.-C.
Published 2014

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

by Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W.
Published 2011

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

by Wong, N.-S., Seah, E.Z.H., Wang, L.-Z., Yeo, W.-L., Yap, H.-L., Chuah, B., Lim, Y.-W., Ang, P.C.S., Tai, B.-C., Lim, R., Goh, B.-C., Lee, S.-C.
Published 2014

Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies

by Yong, W.P., Goh, B.C., Soo, R.A., Toh, H.C., Ethirajulu, K., Wood, J., Novotny-Diermayr, V., Lee, S.C., Yeo, W.L., Chan, D., Lim, D., Seah, E., Lim, R., Zhu, J.
Published 2014

Identification and engineering of 32 membered antifungal macrolactone notonesomycins

by Goh, F., Zhang, M.M., Lim, T.R., Low, K.N., Nge, C.E., Heng, E., Yeo, W.L., Sirota, F.L., Crasta, S., Tan, Z., Ng, V., Leong, C.Y., Zhang, H., Lezhava, A., Chen, S.L., Hoon, S.S., Eisenhaber, F., Eisenhaber, B., Kanagasundaram, Y., Wong, F.T., Ng, S.B.
Published 2021

Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): Prospective cohort study protocol

by Teo, I, Singh, R, Malhotra, C, Ozdemir, S, Dent, R.A, Kumarakulasinghe, N.B, Yeo, W.L, Cheung, Y.B, Malhotra, R, Kanesvaran, R, Yee, A.C.P, Chan, N, Wu, H.Y, Chin, S.M, Allyn, H.Y.M, Yang, G.M, Neo, P.S.H, Nadkarni, N.V, Harding, R, Finkelstein, E.A
Published 2020

Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer

by Yasuda, H., Park, E., Yun, C.-H., Sng, N.J., Lucena-Araujo, A.R., Yeo, W.-L., Huberman, M.S., Cohen, D.W., Nakayama, S., Ishioka, K., Yamaguchi, N., Hanna, M., Oxnard, G.R., Lathan, C.S., Moran, T., Sequist, L.V., Chaft, J.E., Riely, G.J., Arcila, M.E., Soo, R.A., Meyerson, M., Eck, M.J., Kobayashi, S.S., Costa, D.B.
Published 2014